Literature DB >> 78795

Antineoplastic drugs: clinical pharmacology and therapeutic use.

R A Bender, L A Zwelling, J H Doroshow, G Y Locker, K R Hande, D S Murinson, M Cohen, C E Myers, B A Chabner.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 78795     DOI： 10.2165/00003495-197816010-00003

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  277 in total

1.  Uptake and binding of vincristine by murine leukemia cells.

Authors:  W A Bleyer; S A Frisby; V T Oliverio
Journal:  Biochem Pharmacol       Date:  1975-03-01       Impact factor: 5.858

2.  The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line.

Authors:  B Barlogie; B Drewinko; D A Johnston; E J Freireich
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

3.  Pharmacokinetics of vindesine and vincristine in humans.

Authors:  R J Owellen; M A Root; F O Hains
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

4.  The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.

Authors:  R D Warren; A P Nichols; R A Bender
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

5.  Clinical effects and pharmacokinetics of different dosage schedules of adriamycin.

Authors:  W A Creasey; L S McIntosh; T Brescia; O Odujinrin; G T Aspnes; E Murray; J C Marsh
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

6.  Cis-diamminedichloroplatinum (NSC-119875): a phase I study.

Authors:  D J Higby; H J Wallace; J F Holland
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

7.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

8.  Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers.

Authors:  M B Mosher; R C DeConti; J R Bertino
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

9.  PTG, a new antineoplastic epipodyphyllotoxin.

Authors:  P J Creaven; L M Allen
Journal:  Clin Pharmacol Ther       Date:  1975-08       Impact factor: 6.875

10.  Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.

Authors:  C E Myers; R C Young; B A Chabner
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808
View more
  10 in total

Review 1.  Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.

Authors:  W E Evans; M V Relling
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

2.  Modern cancer chemotherapy.

Authors:  K Jain; S Gulati; B Clarkson
Journal:  Indian J Pediatr       Date:  1983 Nov-Dec       Impact factor: 1.967

3.  Increase of corneal graft survival by use of topically immunosuppressive agents in rabbits.

Authors:  S Golubović; B Z Radmanović
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

4.  Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses.

Authors:  M Luyckx; J L Cazin; C Brunet; P Gosselin; M C Demaille
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Drug treatment of breast cancer.

Authors:  T E Davis; P P Carbone
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

7.  Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.

Authors:  R E Finch; M R Bending; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

8.  [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].

Authors:  H J Schmoll; N Niederle; W Achterrath
Journal:  Klin Wochenschr       Date:  1981-11-02

Review 9.  Clinical pharmacology of 5-fluorouracil.

Authors:  R B Diasio; B E Harris
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

10.  Congo Red as a Supramolecular Carrier System for Doxorubicin: An Approach to Understanding the Mechanism of Action.

Authors:  Klaudia Kwiecińska; Anna Stachowicz-Kuśnierz; Beata Korchowiec; Maciej Roman; Wojciech M Kwiatek; Anna Jagusiak; Irena Roterman; Jacek Korchowiec
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.